Opioid monitoring should not stop between monthly visits
Over the past decade, the clinical and regulatory environment surrounding opioid prescribing for chronic non-cancer pain has changed substantially. The 2016 Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain and, more significantly, the updated…
Over the past decade, the clinical and regulatory environment surrounding opioid prescribing for chronic non-cancer pain has changed substantially. The 2016 Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain and, more significantly, the updated 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain established a clearer framework for risk-benefit assessment, dosage considerations, monitoring, and documentation. These guidelines, combined with sustained scrutiny by the …
Opioid monitoring should not stop between monthly visits





















